Neuroscience researchers will detail new technologies at the cutting edge of replacing lost sensory and motor functions, at the October 12 Pre-Meeting Symposium of the American Neurological Association 2019 Annual Meeting from 6–9 p.m. at the Marriott St. Louis Grand. Pioneers in brain-computer interfaces (BCI) will discuss examples of the technology's use, their underlying physiological basis, and how such devices may change the clinical practice of neurology in the near future.
"This symposium will address brain-computer interfaces in neurological therapeutics, with examples including remediating sight in people with visual impairment and restoring hand/arm function and gait in people with stroke or spinal cord injury," said Symposium Chair Steven L. Small, MD, PhD, Professor Emeritus of Neurology at the University of California, Irvine and Dean of the School of Behavioral and Brain Sciences at the University of Texas at Dallas.
An emerging class of medical devices, BCIs translate brain signals into the control of external devices or convert external stimuli into the activation of brain areas. BCIs can enable direct brain control of prostheses or deliver artificial sensation, opening new therapeutic doors for those with neurological deficits or injuries. After decades of research and development, BCI technologies have finally started to enter human clinical studies and clinical trials.